Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Carcinoma, Non-Small Cell Lung

1-methyl-3-isobutylxanthine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allam, M1
Bertrand, R1
Zhang-Sun, G1
Pappas, J1
Viallet, J2
Kaur, G1
Laborda, J1
Blair, O1
Gazdar, AF1
Minna, JD1
Sausville, EA1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Carcinoma, Non-Small Cell Lung

ArticleYear
Cholera toxin triggers apoptosis in human lung cancer cell lines.
    Cancer research, 1997, Jul-01, Volume: 57, Issue:13

    Topics: 1-Methyl-3-isobutylxanthine; Alkaloids; Apoptosis; bcl-2-Associated X Protein; Benzophenanthridines;

1997
Growth inhibition by cholera toxin of human lung carcinoma cell lines: correlation with GM1 ganglioside expression.
    Cancer research, 1992, Jun-15, Volume: 52, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; C

1992